Stockscreener 앱 받기
35.98
1.01%
0.36
시간 외 거래:
35.98
전일 마감가:
$35.62
열려 있는:
$35.63
하루 거래량:
2.99M
Relative Volume:
0.86
시가총액:
$15.55B
수익:
$2.31B
순이익/손실:
$1.66B
주가수익비율:
15.64
EPS:
2.3
순현금흐름:
$827.02M
1주 성능:
-0.94%
1개월 성능:
-3.46%
6개월 성능:
+7.82%
1년 성능:
+23.52%
1일 변동 폭
$35.52
$36.00
1주일 범위
$35.48
$36.99
52주 변동 폭
$24.05
$38.00
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
35.98 | 15.40B | 2.31B | 1.66B | 827.02M | 2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-16 | 개시 | Morgan Stanley | Overweight |
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
Caisse DE Depot ET Placement DU Quebec Boosts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by Hsbc Holdings PLC - MarketBeat
Magnetar Financial LLC Buys Shares of 161,496 Royalty Pharma PLC $RPRX - MarketBeat
GMT Capital Corp Has $74.01 Million Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Will Royalty Pharma plc continue its uptrendJuly 2025 Breakouts & High Yield Equity Trading Tips - Newser
Royalty Pharma acquires lung cancer treatment for $950m - BioXconomy
Royalty Pharma (NASDAQ:RPRX) Raised to "Buy" at Wall Street Zen - MarketBeat
Is Royalty Pharma plc trending in predictive chart modelsEarnings Beat & Technical Entry and Exit Alerts - Newser
Martingale Asset Management L P Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc Starting a New Uptrend getLinesFromResByArray error: size == 0 - thegnnews.com
APG Asset Management N.V. Decreases Stake in Royalty Pharma PLC $RPRX - MarketBeat
Synovus Financial Corp Has $2.60 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc recovery potential after sell offJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - Newser
Royalty Pharma plc stock chart pattern explained2025 Market Overview & Free Real-Time Volume Trigger Notifications - Newser
Is Royalty Pharma plc forming a reversal pattern2025 Year in Review & Verified Stock Trade Ideas - Newser
Campbell & CO Investment Adviser LLC Reduces Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Institutional scanner results for Royalty Pharma plcJuly 2025 Pullbacks & Daily Stock Trend Watchlist - Newser
Using data filters to optimize entry into Royalty Pharma plcWeekly Profit Report & Advanced Swing Trade Entry Alerts - Newser
Candlestick signals on Royalty Pharma plc stock todayPrice Action & AI Forecasted Entry/Exit Points - Newser
How to read the order book for Royalty Pharma plcJuly 2025 Action & Weekly Setup with High ROI Potential - Newser
RSI + MACD Show Convergence for Royalty Pharma plc getLinesFromResByArray error: size == 0 - kangso.co.kr
Compound Planning Inc. Invests $244,000 in Royalty Pharma PLC $RPRX - MarketBeat
Technical signs of recovery in Royalty Pharma plcMarket Trend Review & Verified Technical Signals - Newser
Is Royalty Pharma plc a candidate for recovery playMarket Risk Report & Reliable Trade Execution Plans - Newser
Royalty Pharma plc stock outlook for YEARWeekly Market Outlook & Stock Portfolio Risk Control - Newser
Is a relief rally coming for Royalty Pharma plc holdersJuly 2025 Market Mood & Weekly Breakout Stock Alerts - Newser
Best data tools to analyze Royalty Pharma plc stockRate Cut & AI Enhanced Trading Signals - Newser
Royalty Pharma plc stock volume spike explainedJuly 2025 Summary & Scalable Portfolio Growth Methods - Newser
Will Royalty Pharma plc stock recover after recent dropPortfolio Update Report & Fast Momentum Stock Entry Tips - Newser
Royalty Pharma PLC $RPRX Shares Sold by Northern Trust Corp - MarketBeat
Is Royalty Pharma plc Starting a New UptrendMarket Performance Summary & Fast Momentum Entry Tips - beatles.ru
Royalty Pharma plc stock daily chart insightsWeekly Loss Report & Community Driven Trade Alerts - Newser
Raymond James Financial Inc. Acquires 303,356 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc stock prediction for this weekWeekly Trend Summary & Weekly Breakout Watchlists - Newser
Will Royalty Pharma plc face regulatory challengesJuly 2025 Chart Watch & AI Based Buy/Sell Signal Reports - kpenews.com
Signal strength of Royalty Pharma plc stock in tech scannersJuly 2025 Final Week & Fast Gain Stock Tips - Newser
Published on: 2025-08-29 15:15:46 - Newser
Can swing trading help recover from Royalty Pharma plc lossesWeekly Trade Report & Free Safe Capital Growth Stock Tips - Newser
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):